E-LIB Suche - Ergebnisse für: Pfirrmann, M.

1

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 ..:

Hammersen, J. ; Birndt, S. ; Döhner, K....
Leukemia. 37 (2023) 9 - p. 1879-1886 , 2023

Link: https://doi.org/10.1038/..

2

Interplay of Magnetization Dynamics with a Microwave Wavegu..:

Golovchanskiy, I.A. ; Abramov, N.N. ; Pfirrmann, M....
Physical Review Applied. 11 (2019) 4 - p. , 2019

Link: https://doi.org/10.1103/..

3

Regional deep hyperthermia: quantitative evaluation of pred..:

Aklan, B. ; Zilles, B. ; Paprottka, P....
International Journal of Hyperthermia. 36 (2019) 1 - p. 169-184 , 2019

Link: https://doi.org/10.1080/..

4

Erratum: Expression of the CTLA-4 ligand CD86 on plasmacyto..:

Schütz, C ; Inselmann, S ; Saussele, S...
Leukemia. 32 (2018) 4 - p. 1053-1053 , 2018

Link: https://doi.org/10.1038/..

5

Assessment of imatinib as first-line treatment of chronic m..:

for the SAKK and the German CML Study Group ; Hehlmann, R ; Lauseker, M...
Leukemia. 31 (2017) 11 - p. 2398-2406 , 2017

Link: https://doi.org/10.1038/..

6

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendri..:

Schütz, C ; Inselmann, S ; Sausslele, S...
Leukemia. 31 (2017) 4 - p. 829-836 , 2017

Link: https://doi.org/10.1038/..

7

Secondary malignancies in chronic myeloid leukemia patients..:

Miranda, M B ; Lauseker, M ; Kraus, M-P...
Leukemia. 30 (2016) 6 - p. 1255-1262 , 2016

Link: https://doi.org/10.1038/..

8

Aluminium-oxide wires for superconducting high kinetic indu..:

Rotzinger, H ; Skacel, S T ; Pfirrmann, M...
Superconductor Science and Technology. 30 (2016) 2 - p. 025002 , 2016

Link: https://doi.org/10.1088/..

9

Long-term outcome of patients with newly diagnosed chronic ..:

for the SAKK and the German CML Study Group ; Gratwohl, A ; Pfirrmann, M...
Leukemia. 30 (2015) 3 - p. 562-569 , 2015

Link: https://doi.org/10.1038/..

10

Statistisches Testen in der Onkologie; Statistical testing ..:

Pfirrmann, M.
Der Onkologe. 17 (2011) 4 - p. 337-348 , 2011

Link: https://doi.org/10.1007/..

11

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 ..:

Hammersen, J ; Birndt, S ; Döhner, K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457200/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Oral insulin immunotherapy in children at risk for type 1 d..:

Assfalg, R ; Knoop, J ; Hoffman, K.L...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00125-020-05376-1. , 2021

Link: https://push-zb.helmholt..

13

A practical approach to blinded sample size re-estimation i..:

Pfirrmann, M ; Ziegler, AG
Schoenfeld DA, Richter JR. Nomograms for Calculating the Number of Patients Needed for a Clinical Trial with Survival as an Endpoint. Biometrics. 1982; 38(1):163-170.. , 2021

Link: https://doi.org/10.3205/..

14

Supplementation with Bifidobacterium longum subspecies infa..:

Ziegler, A.-G ; Arnolds, S ; Koelln, A...
info:eu-repo/semantics/altIdentifier/doi/10.1136/bmjopen-2021-052449. , 2021

Link: https://push-zb.helmholt..

15

The EUTOS long-term survival (ELTS) score is superior to th..:

Pfirrmann M ; Clark R. E ; Prejzner W...
info:eu-repo/semantics/altIdentifier/pmid/32601376. , 2020

Link: https://hdl.handle.net/1..